Abstract

The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Diversity and Inclusion in Pancreatic Cancer Clinical Trials
Kelly M Herremans ... Robert A Winn
Gastroenterology | VOL. 161
Kelly M Herremans, et. al.Kelly M Herremans ... Robert A Winn
17 Aug 2021
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic.
Benjamin Besse ... Stefan Michiels
Cancer cell | VOL. 39
Benjamin Besse, et. al.Benjamin Besse ... Stefan Michiels
18 Jun 2021
Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.
Julie M Vose ... Sarah A Holstein
Clinical pharmacology and therapeutics | VOL. 108
Julie M Vose, et. al.Julie M Vose ... Sarah A Holstein
27 Jun 2020
A Qualitative Study of Motivations for Minority Recruitment in Cancer Clinical Trials Across Five NCI-Designated Cancer Centers.
Jennifer A Wenzel ... Zachary R Simoni
Journal of racial and ethnic health disparities | VOL. 4
Jennifer A Wenzel, et. al.Jennifer A Wenzel ... Zachary R Simoni
08 Nov 2016
View more papers

More From: Journal of immunotherapy and precision oncology

Paper Title
Journal
Date
Author
Abstracts Presented at the 2024 Win Symposium in Partnership with Burjeel Holdings: March 1–2 Abu Dhabi, United Arab Emirates
-
Journal of Immunotherapy and Precision Oncology | VOL. -
--
17 May 2024
Decentralized Clinical Trials in Early Drug Development—A Framework Proposal
Diogo J Silva ... Jordi Rodon
Journal of Immunotherapy and Precision Oncology | VOL. -
Diogo J Silva, et. al.Diogo J Silva ... Jordi Rodon
07 May 2024
Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Vincent Mallet ... Harrys A Torres
Journal of immunotherapy and precision oncology | VOL. 7
Vincent Mallet, et. al.Vincent Mallet ... Harrys A Torres
01 May 2024
Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies.
Shubham Pant ... Yali Yang
Journal of immunotherapy and precision oncology | VOL. 7
Shubham Pant, et. al.Shubham Pant ... Yali Yang
01 May 2024
View more papers